Team believes a rational therapeutic design approach will allow scientists to transform how the disease is tackled. Quantum dot technology also should be applicable to other autoimmune diseases as well.

Previous articleSandoz’ Rituximab Biosimilar Rixathon Wins EC Clearance
Next articleSeattle Genetics Halts Enrollment in Vadastuximab Talirine Trials